Frequency Specific Microcurrent (FSM): The Science, Protocols, and Healing Potential of Frequency Medicine's Most Precise Tool

BRMI Staff

A deep exploration of the science, history, condition-specific protocols, and research behind one of integrative medicine's most remarkable — and misunderstood — therapeutic modalities.

The Medicine That Almost Disappeared

Somewhere in a Canadian practice bought in 1946, tucked inside an old osteopathic office, sat a device built in 1922. It came with a list. A list of frequencies. The device was archaic, nearly useless, and the list was filed away and forgotten for decades — until 1995, when a chiropractor named Carolyn McMakin got her hands on that frequency list and decided to try running those numbers through a modern two-channel microcurrent device.

What happened next would quietly change the lives of thousands of patients suffering from conditions that conventional medicine had all but given up on.

That is the origin story of Frequency Specific Microcurrent (FSM) — a therapy born from rediscovery rather than invention, that blends century-old clinical wisdom with cutting-edge cellular science. It is also a story that perfectly illustrates one of the central tenets of frequency medicine: the body communicates in frequencies, and when you know the right ones to speak, healing becomes possible at a level that drugs and surgery simply cannot reach.

First: Where Does Frequency Specific Microcurrent Medicine Fit in the Bigger Picture?

If you've read our companion post on Frequency Medicine Explained: Devices, Science, and What the Evidence Really Says, you already know that frequency medicine is a broad paradigm — one grounded in the understanding that every cell, tissue, and organ in the body has an electromagnetic signature, and that health represents coherence while disease represents disruption in those signals.

Within that broad landscape, several major device categories exist: Pulsed Electromagnetic Field (PEMF) therapy, low-level laser therapy (LLLT), sound and vibroacoustic therapy, bioresonance devices, and microcurrent therapy. FSM lives under the microcurrent branch — but it is far more specialized than general microcurrent.

Here is the key distinction:

• General microcurrent therapy delivers low-level electrical current (in the microampere range) to stimulate cellular repair and ATP production. It has been used in wound care, pain management, and physical therapy for decades.

• PEMF therapy generates pulsed magnetic fields that induce electrical currents in tissue without direct skin contact, with particular strength in bone healing and chronic inflammation.

• FSM takes microcurrent delivery to an entirely different level of precision by pairing two specific frequencies simultaneously — one targeting the condition (such as inflammation, fibrosis, or nerve irritation) and one targeting the specific tissue (such as the spinal cord, fascia, nerve, or liver). This two-channel, condition-and-tissue pairing is what makes FSM fundamentally different from anything else in the frequency medicine toolkit.

  
  

Think of it like this: where general microcurrent is a therapeutic flashlight illuminating an area, FSM is a laser — targeted, precise, and capable of tissue-specific effects that are simply not possible with non-specific approaches.

The Science of Biological Resonance: Why Frequency Matters at the Cellular Level

To understand why FSM works, you need to understand what happens inside a cell when it is injured, inflamed, or diseased — and why frequency might be the key to unlocking recovery.

Cell Membrane Voltage: Your Body's Power Grid

Every healthy cell in your body maintains an electrical charge across its membrane of approximately -70 to -90 millivolts. This is not incidental — it is essential to virtually every cellular function:

• Nutrient transport into the cell

• Waste and toxin removal out of the cell

• ATP (adenosine triphosphate) production — the cell's energy currency

• Protein synthesis for structural repair

• Inter-cellular communication via electromagnetic signaling

When a cell is damaged, inflamed, or chronically stressed, this membrane voltage drops toward zero. The cell loses its ability to produce energy, clear waste, and communicate with its neighbors. This voltage collapse is not just a symptom of disease — it is a core driver of the tissue dysfunction that keeps patients stuck in chronic pain and non-healing states.

The Role of ATP in Healing

ATP is how cells fund the work of repair. Without adequate ATP, a damaged nerve cannot restore its myelin sheath. An inflamed tendon cannot clear inflammatory cytokines. A scarred piece of fascia cannot remodel. Published research has demonstrated that microcurrent stimulation in the microampere range can increase cellular ATP production by up to 500% — a staggering boost that provides the energetic substrate cells need to do the work of healing.

This is one of the clearest mechanisms by which FSM does what it does: it recharges the cellular battery.

Biological Resonance: The Tuning Fork Principle — Explained

Every tissue type — nerve, muscle, fascia, bone, cartilage, organ — has a characteristic resonant frequency, in the same way that a tuning fork vibrates at its own specific note. When tissue is healthy, it vibrates at its natural frequency. When it is injured or diseased, that resonant pattern becomes disrupted.

The theory underlying FSM — supported by a growing body of clinical and laboratory evidence — is that by introducing specific electromagnetic frequencies matched to the resonant properties of a given tissue and condition, the therapy can essentially "retune" the tissue back toward its normal vibrational state. It is the biological equivalent of striking a tuning fork next to another fork of the same pitch: resonance occurs, and function is restored.

This deserves a deeper explanation, because it is one of the most fascinating concepts in all of frequency medicine.

The literal tuning fork phenomenon

When you strike a tuning fork tuned to 440 Hz (the musical note A) and hold it near a second, unstruck 440 Hz fork, the second fork will begin to vibrate and produce sound on its own — without being touched. The sound waves from the first fork travel through the air and cause the second fork to oscillate at its natural frequency. This is resonance: one oscillating system transferring its energy to another system that shares the same natural frequency. The critical word is natural. Hold that 440 Hz fork next to a 523 Hz fork (the note C) and nothing happens. The frequencies don't match, so no energy transfer occurs.

How this maps onto your cells

Every type of biological tissue has its own characteristic electrical oscillation pattern, driven by the activity of its cells. Think of healthy tissue as a tuning fork vibrating cleanly at its natural pitch. When that tissue is injured or diseased, the oscillation becomes disrupted — the cellular "fork" is dampened, out of tune, or vibrating chaotically. Cells lose coherence. They can no longer communicate efficiently, produce energy normally, or coordinate repair.

When FSM introduces a microcurrent carrying the precise frequency that matches that tissue's natural resonant frequency, it is essentially holding a perfectly-pitched tuning fork next to the dampened one. The external frequency provides the "correct pitch" that the tissue has lost — and the tissue begins to entrain back toward that healthy oscillation pattern.

Entrainment: the deeper mechanism

The phenomenon at play is actually entrainment — slightly more profound than simple resonance. Entrainment was first described by physicist Christiaan Huygens in 1665 when he noticed that pendulum clocks mounted on the same wall would gradually synchronize their swings over time, even when started at different moments. The weak vibrations traveling through the wall caused each pendulum to lock onto the dominant rhythm of its neighbors.

Biological entrainment is everywhere in nature. Your circadian rhythm entrains to sunlight. Heart cells in a laboratory dish, placed near a stronger pacemaker cell, will synchronize their beating to match it. Brainwave patterns entrain to rhythmic external stimuli — the basis of neurofeedback and binaural beat therapies.

In FSM, the claim is that diseased or damaged tissue — which has lost its coherent oscillation — will entrain back toward healthy function when exposed to the correct external frequency. The external signal acts as the "lead clock on the wall," and disrupted tissue gradually synchronizes to it.

Why this explains FSM's specificity

This is exactly why the wrong frequency does nothing, and why a practitioner cannot simply apply any current and achieve FSM's results. A 10 Hz signal targeting spinal cord tissue does not affect liver tissue — because the liver's natural resonant frequency is different (approximately 3 Hz in published FSM protocols). The liver does not "hear" a 10 Hz signal as its own pitch, so no resonance or entrainment occurs. This is also precisely why FSM differs fundamentally from general microcurrent, which delivers current without matching any particular tissue's resonant frequency.

It also explains one of FSM's most clinically dramatic phenomena: the immediate tissue softening that occurs within seconds of applying the correct frequency pair. The tissue doesn't gradually respond over minutes — it responds almost instantaneously, the way a tuning fork begins to vibrate the moment the matching pitch reaches it. There is no lag time in resonance. The signal arrives, the match is recognized, and the response is immediate.

An honest note on the science

The tuning fork model is physically plausible and consistent with established principles of resonance, entrainment, and bioelectromagnetics. Published peer-reviewed research — including a 2013 paper by McMakin and biophysicist James Oschman in the Journal of Alternative and Complementary Medicine — specifically invokes resonance as the likely mechanism, noting that "the high degree of frequency specificity of FSM indicates that resonance is probably involved in the mechanism of action, in which the applied current is resonating with charged particles or dipoles in the tissues." The same paper draws a direct parallel with MRI, which is itself based on resonant interactions between electromagnetic fields and protons in tissue — a technology that no one calls pseudoscience.

What remains incomplete is the full molecular-level map of how a specific electromagnetic frequency carried in microampere current translates into a cascade of cellular biological changes. What we have in abundance is the downstream evidence: the cytokine reductions, the immediate tissue softening, the ATP increases, and the reproducible clinical outcomes across thousands of patients and practitioners. The tuning fork is the best available metaphor for a phenomenon that the evidence strongly suggests is real — even as the mechanistic picture continues to be filled in.

The Two-Channel Innovation

What makes FSM uniquely powerful within frequency medicine is its simultaneous delivery of two independent frequencies through a single application:

• Channel A carries the frequency associated with the condition — inflammation (40 Hz), fibrosis or scar tissue (13 Hz), nerve irritation (94 Hz), hemorrhage (18 Hz), and dozens of others.

• Channel B carries the frequency associated with the tissue — the spinal cord (10 Hz), the nerve (396 Hz), fascia (77 Hz), the liver (3 Hz), muscle (62 Hz), and so on.

These two frequencies are delivered simultaneously using polarized, positive direct current with a ramped square-wave pulse — at a current measured in microamps, roughly 1/1,000th of the intensity of a TENS unit. The current is so low it cannot be felt. And yet the tissue response can be immediate and dramatic.

The Frequency Codes: What Has Been Published

A natural question at this point is: what are the actual frequency numbers? This deserves a transparent answer.

The complete FSM frequency list — covering over 200 conditions and tissues — is proprietary to Dr. McMakin's clinical training program and her Elsevier textbook (Frequency Specific Microcurrent in Pain Management, 2010). It is deliberately not published in its entirety on public websites, for the same reason that a surgical technique manual is not distributed to the general public: these protocols require trained clinical judgment to apply safely and effectively. The wrong frequency for the wrong diagnosis does nothing at best; a few frequency applications carry specific contraindications (such as the anti-fibrosis frequency, which should not be used within six weeks of a new injury, as it can disrupt early scar formation that is necessary for structural healing).

However, a meaningful set of the most clinically researched and widely referenced frequency pairs has been published in peer-reviewed journals and publicly available clinical literature. These are listed below as a reference for practitioners and informed readers:

Channel A (Condition)	Hz	Channel B (Tissue)	Hz	Clinical Application
Reduce inflammation	40	Spinal cord	10	Fibromyalgia/spine trauma (NIH-validated cytokine reduction)
Reduce inflammation	40	Nerve	396	Neuropathic and nerve-related pain
Reduce inflammation	40	Muscle	62	Muscle inflammation, DOMS
Reduce inflammation	40	Fascia	77	Fascial inflammation, myofascial pain
Reduce fibrosis/scar	13	Fascia	77	Fascial scar tissue remodeling
Reduce fibrosis/scar	13	Muscle	62	Muscle scar tissue
Viral/shingles protocol	230	(specific pair)	430	Shingles — pain elimination in ~20 min
Reduce inflammation	40	Liver	3	Liver inflammation, elevated enzymes
Anti-LOX inflammation	40	(mouse model pair)	116	62% swelling reduction in published animal trial
Autonomic balance	(specific)	Medulla	(specific)	ANS rebalancing, serotonin normalization

Note: Frequencies are measured in Hz (pulses per second). All FSM frequencies fall below 1000 Hz. The above represents the subset of published, peer-reviewed, or widely cited clinical literature — not the complete protocol library, which is available through formal FSM training.

What is striking about this table is the precision required. It is not sufficient to use "approximately 40 Hz" for inflammation — devices must deliver three-digit accuracy (e.g., 40.0 Hz, not 38 or 42). This is why standard TENS units cannot replicate FSM: they do not offer this level of frequency specificity, and they operate at 1,000 times the current level, which overrides the subtle resonance mechanisms entirely.

The History: From Osteopathic Frequencies to Modern Medicine

The frequencies used in FSM were not invented by Carolyn McMakin — they were developed between approximately 1910 and 1934 by medical and osteopathic physicians who were using them with early electrotherapy machines that have long since been forgotten. When conventional medicine narrowed its focus to drugs and surgery in the late 1920s, frequency-based therapies were effectively abandoned in North America.

The lineage that survived did so by accident. An osteopath named Harry VanGelder bought a practice in Canada in 1946. It came with a device from 1922 and a handwritten list of frequencies. VanGelder's student George Douglas kept a copy of that frequency list. In 1983, Douglas filed it away. In 1995, he found it again — and gave it to Carolyn McMakin.

McMakin, then a chiropractor specializing in fibromyalgia and myofascial pain in Portland, Oregon, immediately recognized the clinical potential. She began treating patients using the frequencies as described on the list, running them through a modern two-channel microcurrent device. The results were striking. Frequencies described as reducing inflammation did reduce inflammation — and nothing else. Frequencies described as softening scar tissue increased range of motion — but had no effect on inflammation. The specificity was unmistakable.

By January 1997, McMakin began teaching the technique to other practitioners. By June 1997, it was clear from independent practitioners' results that the effects were reproducible and teachable — not placebo, not a fluke. FSM was a real clinical tool.

Today, FSM is practiced by over 10,000 trained practitioners worldwide. It is used at the Cleveland Clinic and Walter Reed Medical Center. McMakin has authored multiple peer-reviewed papers and a textbook published by Elsevier (Frequency Specific Microcurrent in Pain Management, 2010), and has lectured at the National Institutes of Health. What began as a dusty list of frequencies has become a clinical discipline with its own body of research, practitioner community, and rapidly expanding evidence base.

What a Session Looks Like: The Practical Experience

One of FSM's most notable features — both for patients and skeptical practitioners — is its complete absence of sensation. Because the current is delivered in the microampere range (millionths of an amp), patients typically feel nothing from the electrical current itself.

Delivery Methods

FSM can be delivered in several ways depending on the treatment area:

• Graphite conductive gloves inserted into warm, moist hand towels or face cloths placed on the treatment area

• Gel electrode patches applied directly to the skin at specific anatomical sites

• Wet towel wraps for larger body regions such as the back or limbs

The practitioner applies the delivery method to the appropriate anatomical locations — which depend on the condition being treated — and runs through a protocol sequence of frequency pairs.

The Tissue Softening Response

One of the most clinically dramatic and reproducible findings in FSM is what practitioners call tissue softening: a palpable, profound change in tissue texture that occurs within seconds of applying a frequency combination that is appropriate for the condition being treated. Tight muscles become soft. Inflamed, ropy fascia loses its tension. Trigger points release. This softening is so immediate and consistent — occurring in seconds, not minutes — that it has become a key clinical marker indicating that the correct frequency pair has been selected.

Published research in peer-reviewed journals, including a 2013 paper in the Journal of Alternative and Complementary Medicine by McMakin and biophysicist James Oschman, has examined the mechanism behind this tissue softening and concluded it likely involves a restoration of normal muscle tone mediated by changes in the gamma motor neuron loop — the same neurological circuit that governs baseline muscle tension throughout the body.

Hydration Is Non-Negotiable

Because FSM works with electrical currents moving through tissue, the therapy is highly dependent on tissue hydration. Water is an electrical conductor; dehydrated tissue dramatically reduces the effectiveness of the treatment. Practitioners universally recommend that patients drink 8–10 glasses of water on treatment days, with a minimum of one quart in the two hours before a session.

What to Expect After Treatment

Most patients experience some beneficial effect immediately following treatment. Common post-session responses include:

• Reduction in pain, often dramatic

• Increased warmth and relaxation in treated areas

• Decreased swelling or visible softening of scar tissue

• Improved range of motion

A subset of patients experiences what practitioners describe as a detox reaction — mild fatigue, temporary nausea, or a brief flu-like feeling — as FSM's rapid mobilization of cellular waste products and inflammatory mediators can temporarily overwhelm the body's clearance pathways. This response is short-lived and can be mitigated with adequate hydration and by adjusting treatment intensity.

Condition-Specific Protocols: The Clinical Heart of FSM

This is where FSM becomes truly extraordinary. Unlike most therapeutic modalities that offer general benefits across broad categories of conditions, FSM has developed distinct, reproducible protocols for specific diagnoses — right down to the exact frequency pairs that have been clinically documented to produce specific effects. What follows is the most extensive section of this post, because this is where the real clinical story lives.

1. Fibromyalgia Associated with Spine Trauma

Of all the conditions that FSM addresses, this may be the one with the most compelling — and most precisely documented — clinical evidence.

There are two fundamentally different types of fibromyalgia. The most common presents with widespread pain and sleep disruption but without neurological findings. The second type — fibromyalgia associated with spine trauma — is far more severe, far more treatment-resistant, and characterized by distinct neurological signs: hyperactive patellar reflexes, dermatomal hyperesthesia (abnormal skin sensitivity in specific nerve distributions), and a complete failure to respond to opioid medications.

McMakin identified this distinction early in her FSM work and found that only one frequency combination — 40 Hz on Channel A (to reduce inflammation) combined with 10 Hz on Channel B (targeting the spinal cord) — produced any effect in this patient population.

The clinical results documented in her published studies are extraordinary:

• In 45 patients with this diagnosis, pain scores were reduced from an average of 7.3/10 to 1.3/10 in 45 minutes of treatment.

• Blood samples analyzed by immunochemist Terry Phillips, PhD at the NIH documented log-rate reductions in inflammatory cytokines — interleukin-1 dropped from 330 to 80 pg/ml; interleukin-6 from 239 to 76 pg/ml; TNF-α from 305 to 78 pg/ml; and substance P from 180 to 54 pg/ml — reductions of 10 to 20 times, in response to this specific frequency combination and no other.

• Endorphin levels increased from 8.2 to 71.1 pg/ml — a nearly ninefold increase.

• Serotonin, interestingly, initially dropped as pain resolved, but when the protocol was shifted to target the medulla oblongata to rebalance the nervous system, serotonin levels increased — in one case more than doubling in 30 minutes.

• Fifty-eight percent of patients treated with this protocol fully recovered from fibromyalgia within 4 months.

This is not a modest incremental improvement. These are the kinds of results — cytokine reductions of this magnitude, in this timeframe, with this specificity — that conventional pharmacology cannot approach without significant side effects.

To be clear: this protocol does not work in patients whose fibromyalgia was not triggered by spine trauma and whose neurological signs are normal. The tissue-and-condition specificity is the entire point. Wrong diagnosis, wrong protocol, no effect. Correct diagnosis, correct protocol, dramatic effect.

2. Shingles and Post-Herpetic Neuralgia

Shingles (herpes zoster reactivation) produces one of the most severe and treatment-resistant pain syndromes in medicine. Post-herpetic neuralgia — the nerve pain that persists after the acute outbreak — can last for years and is notoriously resistant to conventional pharmacotherapy.

FSM has a single, highly specific protocol for shingles, described in McMakin's published paper in Practical Pain Management (2010). The frequency combination is 230 Hz on Channel A (targeting viral activity) combined with 430 Hz on Channel B, delivered simultaneously using 150 microamps of polarized positive direct current.

The clinical outcomes documented anecdotally and in case reports are among the most dramatic in the FSM literature:

• Pain is eliminated in approximately 20 minutes in most patients.

• Shingles lesions typically dry up and disappear within 2–3 days rather than the usual 2–4 weeks.

• Post-herpetic neuralgia — often considered untreatable without long-term medication — responds to this protocol even in established cases.

Practitioners consistently note that this frequency combination is specific to shingles — it does not produce these effects for other types of nerve pain or skin lesions. The specificity is, again, the hallmark of FSM: the frequency matters, the tissue matters, and the intersection of the two is where healing occurs.

3. Neuropathic Pain

Neuropathic pain — pain arising from damaged or dysfunctional nerves rather than injured tissue — is one of the most difficult categories in pain medicine. Standard analgesics are largely ineffective; first-line treatments (gabapentinoids, tricyclic antidepressants, SNRIs) provide meaningful relief in fewer than half of patients and carry significant side effect burdens.

McMakin's published case series in The Pain Practitioner (2010) documented outcomes in 77 patients with confirmed neuropathic pain diagnoses, of whom 20 met strict inclusion criteria. Results showed significant, clinically meaningful pain reduction using FSM protocols targeting inflammation and nerve tissue.

The mechanism is distinct from TENS-style pain modulation. Rather than jamming the pain signal (the gate-control approach of TENS), FSM appears to work by reducing the neuroinflammation that sustains neuropathic pain states — reducing cytokine load, improving cellular ATP production, and allowing the nerve to begin the slow process of structural repair.

FSM is particularly noted for applications in:

• Peripheral neuropathy (including diabetic peripheral neuropathy)

• Cervical, thoracic, and lumbar radiculopathies — nerve pain arising from disc and facet pathology in the spine

• Post-surgical nerve pain — one of the most common and difficult sequelae of spinal surgery

• Complex Regional Pain Syndrome (CRPS) — a condition characterized by severe, disproportionate nerve pain and autonomic dysfunction following injury

The research registry at frequencyspecific.com documents clinical case reports for all of these conditions, with protocols addressing both the involved nerve tissue and the specific pathological condition driving the pain.

4. Chronic and Acute Low Back Pain and Neck Pain

Low back pain is the single leading cause of global disability. Neck pain is not far behind. And while conventional physical therapy, manual therapy, and medications provide benefit for many patients, a substantial proportion — particularly those with chronic, recurrent, or post-surgical spinal pain — continue to suffer.

The 2020 publication in the Journal of Bodywork and Movement Therapies (Shetty, Rawat, and Sharma) provides the highest-quality independent evidence to date for FSM in spinal pain. In this retrospective case-control study of 291 patients:

• 213 patients received FSM as an adjunct to standard physical rehabilitation for low back or neck pain.

• 78 patients received standard rehabilitation alone.

• In the low back pain group, FSM significantly improved both pain scores (Numerical Pain Rating Scale) and disability scores (Oswestry Disability Index) compared to controls.

• The FSM group showed better treatment outcome categories, with more patients achieving clinically meaningful recovery.

• The effect in neck pain did not reach statistical significance — an honest finding that suggests FSM's benefit may be more pronounced in the lumbar spine specifically, possibly due to differences in anatomical complexity or the prevalence of disc and facet pathology.

Beyond this study, FSM practitioners document robust outcomes in:

• Disc-related pain — FSM can address disc tissue directly, targeting the inflammatory processes within and around the disc

• Facet syndrome — inflammation of the facet joints responds well to protocols combining anti-inflammatory frequencies with facet joint tissue targeting

• Myofascial components of spinal pain — the frequent co-occurrence of tight, fibrotic paraspinal muscles and trigger points with spinal pathology is directly addressed by FSM's tissue-softening effects

• Post-surgical spinal pain — particularly important given the high rates of failed back surgery syndrome (FBSS), FSM can address the scar tissue, neural inflammation, and soft tissue dysfunction that often persist after spine surgery

A military treatment facility study published in Advances in Integrative Medicine (Moss et al., 2024) evaluated 761 patients over three years in a physician-led integrative medicine clinic at a large Air Force facility, where microcurrent therapy was one of the primary modalities. On average, pain scores were reduced from 4.4 to 1.5 on the Defense and Veterans Pain Rating Scale, and quality-of-life scores improved by 16.5% — outcomes achieved in a complex, often treatment-resistant military population.

5. Traumatic Brain Injury, Concussion, and Neurological Rehabilitation

TBI and concussion represent some of the most complex clinical challenges in modern medicine, with limited effective pharmacological interventions and an enormous unmet need. FSM has been working in this space since 1997.

Protocols for concussion and TBI target multiple aspects of the neurological disruption: addressing inflammation in brain tissue, supporting mitochondrial function in neurons, reducing autonomic nervous system dysregulation, and facilitating the repair of white matter pathways.

A 2024 registered clinical trial (NCT06245967, listed in the Cochrane Central Register) is currently underway examining FSM therapy for mild traumatic brain injury — a significant development representing growing mainstream research interest.

Earlier observational work documented:

• In 2013, Alicia Thomas, EdD documented significant EEG changes in TBI patients treated with a combination of FSM and speech therapy processes.

• Roger Billica, MD documented rapid, dramatic changes in heart rate variability in response to specific frequencies targeting the sympathetic and parasympathetic nervous system, demonstrating direct effects on autonomic regulation.

A published case series in Medical Acupuncture (Sharp, Huynh, and Filart, 2019) documented FSM as adjunctive therapy in three wounded warriors, with clinically meaningful improvements in pain, function, and quality of life — representing the growing use of FSM in veteran care at facilities such as Walter Reed.

For athletes, concussion protocols using FSM address not only acute inflammation but also the post-concussion syndrome spectrum — cognitive fog, sleep disruption, headache, and mood changes — that often persists well beyond the initial injury.

6. Delayed Onset Muscle Soreness (DOMS) and Athletic Performance

One of the highest-quality published studies in the FSM literature examined its effect on delayed onset muscle soreness (DOMS) — the muscle pain and stiffness that peaks 24–72 hours after unaccustomed intense exercise. This was a blinded, controlled trial published in the Journal of Bodywork and Movement Therapies (Curtis, Fallows, Morris, and McMakin, 2010).

Results demonstrated that a single FSM treatment within 24 hours of the exercise bout significantly reduced DOMS compared to controls — with pain reduction, improved range of motion, and improved muscle function.

The mechanism here maps directly onto FSM's cellular effects: reducing inflammation in muscle tissue, improving ATP availability for repair, accelerating the removal of metabolic waste products, and modulating the inflammatory cascade that drives DOMS symptomatology.

For competitive athletes, this has practical implications. FSM can:

• Compress recovery time between training sessions

• Address acute sports injuries (strains, sprains, tendinopathies) with accelerated healing

• Reduce post-surgical recovery time when applied within 4 hours of surgery

• Enhance neuromuscular function by addressing the fascial and soft tissue restrictions that limit performance

Practitioners note that acute injuries treated with FSM within 4 hours of occurrence show dramatically faster healing trajectories — with some reporting healing acceleration of up to 200%. Beyond the 12-hour window, healing still proceeds, but at an accelerated rather than dramatically compressed rate.

7. Myofascial Pain Syndrome and Trigger Points

Myofascial pain — pain arising from trigger points (hyperirritable spots in taut bands of muscle) — is estimated to be present in 85% of patients attending pain clinics. It is extraordinarily common and yet inadequately addressed by most conventional treatments.

McMakin's first published paper (1998, Topics in Clinical Chiropractic) documented the treatment of chronic, resistant myofascial pain in the head, neck, and face using FSM. This was the foundation of the FSM clinical evidence base and established both the therapeutic approach and the remarkable tissue-softening response that would become a clinical hallmark.

FSM protocols for myofascial pain address:

• The taut muscle bands and trigger points directly, using frequencies targeting muscle tissue and the specific condition (fibrosis, inflammation, chronic contraction)

• Fascia — the connective tissue matrix that encases every muscle — with anti-fibrosis frequencies that can remodel fascial restrictions that would require months of manual therapy to address manually

• The visceral contributions to myofascial pain — the clinically important observation that organ dysfunction (a tight psoas from a digestive problem, rib restrictions from diaphragm adhesions) often drives myofascial patterns that resist treatment until the visceral component is addressed

FSM is particularly valuable in conditions like temporomandibular joint (TMJ) dysfunction, tension headaches, and thoracic outlet syndrome where myofascial components are central but difficult to reach with manual techniques alone.

8. Scar Tissue, Burns, and Wound Healing

Scar tissue is one of FSM's flagship applications, and the mechanism is well-supported: the frequency combination targeting fibrosis (13 Hz) with the specific tissue frequency produces a dramatic, immediate softening and remodeling of scar tissue that practitioners consistently observe in seconds of application.

A feasibility study published in 2003 documented the use of microcurrent combined with silver-plated nylon dressings in human burn patients, demonstrating enhanced wound healing outcomes. Subsequent clinical work has extended this to:

• Surgical scars — both fresh and old, thick, restricting scars respond to FSM protocols

• Adhesions — particularly abdominal and pelvic adhesions following surgery or infection, which can cause chronic pain and organ dysfunction, and which are notoriously difficult to address without repeat surgery

• Keloid and hypertrophic scarring — excess scar tissue formation that can cause both functional and aesthetic problems

• Post-radiation fibrosis — a 1999 publication examined microcurrent therapy for late radiation effects in head and neck cancer patients, finding benefits in tissue quality and symptom reduction

The clinical observation that FSM can remodel in one session scar tissue that would take months of manual therapy to address is one of the most clinically impactful claims in the literature — and one that experienced practitioners consistently corroborate.

9. Kidney Stone Pain

This is one of the most specific and reproducible single-outcome applications in all of FSM clinical practice. There is one frequency combination that has been documented as essentially universally effective in eliminating kidney stone pain — and it does so without removing the stone. Pain relief is typically complete and often occurs within minutes of treatment.

This is not a small clinical observation. Renal colic — the pain of a kidney stone — is widely considered among the most severe pain experiences a human can undergo, routinely described by patients as worse than childbirth. The fact that a specific, non-pharmacological frequency combination can eliminate that pain in minutes — without narcotics, without NSAIDs, without procedures — is clinically remarkable.

Practitioners are careful to note that the stone itself is not dissolved or removed; patients still need to pass or treat the stone through conventional means. But the FSM protocol provides pain control in an extremely difficult situation where even strong analgesics often fail to provide adequate relief.

10. Autonomic Nervous System Dysregulation, PTSD, and Stress

One of the most exciting and rapidly expanding frontiers of FSM is its effects on the autonomic nervous system (ANS) — the division of the nervous system that regulates heart rate, blood pressure, digestion, immune function, and the stress response.

The autonomic nervous system is increasingly recognized as central to a wide range of chronic conditions: fibromyalgia, chronic fatigue syndrome, POTS, PTSD, anxiety disorders, irritable bowel syndrome, and many others involve ANS dysregulation at their core.

FSM protocols targeting the sympathetic and parasympathetic nervous system produce measurable, documented effects:

• Roger Billica, MD's 2013 documentation showed that applying a frequency targeting secretions of the sympathetic nervous system for just 60 seconds produced a dramatic, measurable increase in sympathetic tone visible on heart rate variability (HRV) monitoring — direct, objective physiological evidence of frequency-specific autonomic effects.

• The frequency to balance the parasympathetic system produced the corresponding shift in HRV in the opposite direction.

The 2025 randomized controlled pilot trial published in Healthcare (Pereira et al.) — the most rigorously designed FSM study to date — recruited patients with clinically significant stress and randomized them to FSM alone, FSM plus relaxation, relaxation alone, or placebo. After six sessions:

• FSM participants reported fewer somatic symptoms and negative emotions than those receiving relaxation alone.

• Significant improvements were seen in perceived stress, emotional distress, emotion regulation, and self-efficacy.

• The FSM group showed improvements in serenity scores that were not achieved by the relaxation control.

For PTSD specifically, FSM addresses both the neurological components (calming an overactivated sympathetic nervous system, reducing the inflammatory burden in brain tissue associated with trauma) and the somatic components (releasing the myofascial tension that stores and perpetuates traumatic stress in the body's tissues). FSM is among the modalities used at Walter Reed and other military treatment facilities in veteran PTSD care.

11. Emerging and Newer Protocols

Research and clinical innovation in FSM is ongoing. Several newer application areas deserve mention:

Scleroderma and Raynaud's Syndrome A 2025 pilot study published in Rheumatology (Gregory, Bagley, Eng, McMakin, and Del Galdo) documented that FSM improved hand function and reduced Raynaud's symptoms in scleroderma patients — a condition characterized by progressive tissue fibrosis and vascular dysfunction, for which treatment options are severely limited. This represents the first peer-reviewed evidence for FSM in a systemic autoimmune disease context.

Dense Breast Tissue A 2023 case report in Journal of Women's Health documented FSM treatment in a 54-year-old woman with heterogeneously dense breast tissue (Category C on mammography). Post-treatment mammography showed improvement in tissue density — a finding with implications for both breast cancer risk and mammogram comfort and accuracy.

Knee Osteoarthritis A registered clinical trial examining the anti-inflammatory effects of FSM in osteoarthritic adults (NCT06390137, registered 2024 in the Cochrane Central Register) is underway. Preliminary clinical reports from practitioners suggest meaningful improvements in pain, swelling, and function — positioning FSM as a potential non-surgical, non-pharmacological option in a condition where the conventional treatment algorithm culminates in joint replacement surgery.

Hypermobility Spectrum Disorders A 2025 case report in the British Journal of Healthcare and Medical Research documented FSM treatment of hypermobility spectrum disorders — a group of connective tissue conditions characterized by joint instability, chronic pain, and fatigue. FSM's ability to address fascial laxity, reduce neuroinflammation, and support tissue integrity makes it a logical fit for this population.

Interstitial Cystitis and Pelvic Pain Practitioners document FSM protocols targeting bladder tissue and pelvic floor dysfunction for conditions like interstitial cystitis, vulvodynia, endometriosis, and pelvic adhesions — conditions that are notoriously difficult to treat and where patients frequently cycle through multiple failed therapeutic attempts before finding relief.

Visceral Conditions McMakin and Oschman's 2013 peer-reviewed publication specifically addressed visceral and somatic disorder treatment with FSM, documenting clinical protocols for sinus conditions, liver dysfunction (reducing elevated liver enzymes, presented at the American Academy of Anti-Aging Medicine in 2009), irritable bowel syndrome, and ovarian cysts — expanding FSM's reach well beyond the musculoskeletal domain where it is most commonly discussed.

The Research Landscape: What the Evidence Really Says

What the Evidence Supports

Microcurrent mechanisms are well-established. The finding that microcurrent in the microampere range increases ATP production is not contested — it has been replicated in multiple laboratory studies. The anti-inflammatory effects of specific frequency combinations (particularly the 40 Hz / 116 Hz combination in the mouse model of LOX-mediated inflammation, which produced a 62% reduction in swelling compared to controls) have been documented in controlled animal research.

Clinical outcomes in key conditions are documented. The fibromyalgia-spine-trauma cytokine data, independently analyzed at the NIH, represents some of the most rigorous biomarker evidence in the FSM literature. The DOMS study was a blinded, controlled trial with objective and subjective outcomes. The 2020 low back pain study (Shetty et al.) was a case-control study of nearly 300 patients, published in a legitimate peer-reviewed journal. The 2025 Portuguese RCT is the first true randomized controlled trial with placebo controls. The military chronic pain outcomes data spans 761 patients over three years.

Tissue softening is a reproducible, clinically verifiable phenomenon. The palpable, near-immediate softening of tissue in response to appropriate frequency pairs has been documented, described, and discussed in the peer-reviewed literature. It is observable by trained practitioners and cannot easily be explained as placebo, given its immediacy and the fact that the patient cannot feel the current.

Practitioner reproducibility has been demonstrated. Since 1997, the FSM clinical community has grown to over 10,000 trained practitioners worldwide. The protocols are taught in standardized courses, the effects are reproducible across practitioners and patient populations, and the feedback from clinical practice continuously refines and validates the protocols.

The Legitimate Critiques

Intellectual honesty requires acknowledging the real limitations of the current evidence base.

The research base remains thin in volume. There are simply not many published randomized controlled trials for FSM. Much of the clinical evidence is case reports, case series, and retrospective studies — valuable but not sufficient to meet the evidentiary standards required for mainstream clinical adoption.

Much of the early research was conducted by the originator. When a significant proportion of the published work comes from the developer of the therapy, independent replication — the cornerstone of scientific validity — becomes paramount. The good news is that this is changing: the scleroderma study (2025), the Portuguese RCT (2025), the military outcomes data (2024), and the registered clinical trials currently underway represent genuine independent research momentum.

Mechanistic questions remain open. How exactly do specific frequency pairs produce tissue-specific effects at microampere current levels? The biological resonance explanation is plausible and consistent with established physics, but it has not been mechanistically proven at the molecular level. Critics who call the theory pseudoscientific are overstating their case — physics does not prohibit frequency-specific biological effects — but the mechanistic proof is incomplete.

Blinding in FSM research is methodologically challenging. Because the treatment produces observable tissue changes and patient responses, true blinding of practitioners is difficult. Placebo controls (delivering electrodes without current) are feasible and have been used in the most recent trials, but earlier studies lacked these controls.

The Trajectory Is Positive

The honest summary: FSM has a strong clinical signal, a growing body of independent research, documented biological mechanisms, and a safety profile that is essentially without serious risk. It does not yet have the volume of large RCT data that characterizes fully evidence-validated conventional therapies. This gap is closing rapidly, particularly with new trials registered in the Cochrane system and independent research groups publishing in mainstream peer-reviewed journals. For patients whose conditions have not responded to conventional care, and for practitioners integrating FSM into evidence-informed practice, the current evidence is sufficient to justify use — with appropriate framing as an adjunctive and complementary modality.

Who Is Using FSM — and Where

The institutional landscape for FSM has expanded considerably from its origins in alternative health circles:

• The Cleveland Clinic lists FSM in its health library as a recognized therapeutic option for musculoskeletal pain management.

• Walter Reed National Military Medical Center has used FSM as part of integrative pain management for wounded service members, as documented in the Medical Acupuncture case series.

• Air Force integrative medicine clinics have incorporated microcurrent therapy (including FSM) with documented outcomes in large patient cohorts.

• Integrative oncology programs are exploring FSM for radiation side effects, post-surgical recovery, and quality-of-life support.

• Sports medicine applications are growing, with athletic trainers, physical therapists, and sports medicine physicians using FSM for accelerated injury recovery and performance optimization.

• Chiropractic, naturopathic, and osteopathic medicine has a long history of FSM adoption, as these disciplines tend to embrace physiological rather than purely pharmacological approaches to healing.

Practitioner training is formalized through Dr. McMakin's FSM courses — a 40-hour online core curriculum plus hands-on practicums — that have trained over 10,000 healthcare professionals across medicine, chiropractic, physical therapy, naturopathy, acupuncture, and nursing.

Safety Profile and Contraindications

One of FSM's most compelling practical advantages is its extraordinarily favorable safety profile. Because the current levels used are so low — operating in the same microampere range as the body's own endogenous electrical activity — FSM is essentially free of serious adverse effects.

Documented side effects are mild, transient, and primarily consist of:

• Fatigue following treatment (as the body processes mobilized waste products)

• Temporary nausea or mild flu-like symptoms in response to rapid cellular detoxification

• A brief, temporary increase in soreness — similar to what some patients experience after deep tissue massage

These effects are short-lived, resolve with rest and hydration, and are not a contraindication to continued treatment.

Contraindications and cautions include:

• Pregnancy — electrical stimulation of any kind is generally avoided during pregnancy

• Implanted electronic devices — pacemakers, implanted defibrillators, or spinal cord stimulators preclude FSM use in adjacent areas

• Active cancer — while some integrative oncology programs are exploring FSM, the increased cellular metabolism it induces warrants caution in active malignancy

• Acute infections — treating actively infected tissue is contraindicated

• Over the carotid sinuses — electrical stimulation in this area can affect heart rate

• Thrombosis — stimulation over areas of known blood clots is avoided

How to Find an FSM Practitioner

Because FSM requires precise diagnostic judgment and protocol selection, it is important to seek a practitioner who has completed formal training through the official FSM curriculum — not simply someone who owns a microcurrent device.

The official practitioner directory is maintained at frequencyspecific.com/practitioners. Listed practitioners have completed Dr. McMakin's rigorous core training, passed competency testing, and keep current with updated protocols. This is the most reliable starting point for finding a qualified FSM provider.

When searching for a practitioner, you may find FSM offered by:

• Chiropractors — the discipline most deeply integrated with FSM since its inception

• Physical therapists — particularly those working in integrative or sports medicine settings

• Naturopathic physicians — who often incorporate FSM as part of broader bioregulatory treatment programs

• Osteopathic physicians and MDs — increasingly, especially in integrative and functional medicine practices

• Licensed acupuncturists — particularly those trained in bioelectromagnetic approaches

• Sports medicine practitioners — where FSM's performance and injury recovery applications are growing rapidly

When speaking with a prospective practitioner, useful questions include: Have you completed the FSM Core training with Dr. McMakin? Do you use a two-channel device capable of three-digit frequency accuracy? Do you have experience treating my specific condition? How many sessions would you anticipate for my situation?

FSM devices used by trained practitioners are FDA-cleared medical devices (under the TENS device category) available only to licensed practitioners or by physician prescription. Consumer-grade single-channel microcurrent devices sold over the counter are not FSM devices and cannot replicate the two-channel frequency-pairing that is the basis of FSM therapy.

Conclusion

FSM is frequency medicine's most precise clinical instrument — a modality that doesn't just support healing broadly, but speaks the specific electromagnetic language of individual tissues and conditions. Where PEMF casts a wide therapeutic net, FSM uses a targeted signal: matching frequencies to tissue, condition to protocol, and cellular disruption to resonant correction.

The research is growing, the practitioner community is expanding, and the patients finding relief — after years of failed conventional treatment — tell the most compelling story of all. If you or someone you care for is navigating chronic pain, treatment-resistant inflammation, or a complex condition that hasn't responded to standard care, FSM may be the missing conversation your body has been waiting to have.

References

• McMakin CR, Oschman JL. Visceral and somatic disorders: tissue softening with frequency-specific microcurrent. J Altern Complement Med. 2013;19(2):170-7. PMC3576917.

• Shetty GM, Rawat P, Sharma A. Effect of adjuvant frequency-specific microcurrents on pain and disability in patients treated with physical rehabilitation for neck and low back pain. J Bodywork Mov Ther. 2020;24(4):168-175.

• Curtis D, Fallows S, Morris M, McMakin C. The efficacy of frequency specific microcurrent therapy on delayed onset muscle soreness. J Bodywork Mov Ther. 2010;14(3):272-9.

• Pereira MG, et al. Effectiveness of Frequency-Specific Microcurrent (FSM) Therapy and Relaxation in Adults with Distress: A Pilot Randomized Controlled Trial. Healthcare (Basel). 2025;13(10):1151.

• Gregory WM, Bagley K, Eng S, McMakin C, Del Galdo F. Frequency specific microcurrent improves hand function and Raynaud's symptoms in scleroderma: results of two pilot studies. Rheumatology. 2025. doi:10.1093/rheumatology/keaf301.

• Sharp SJ, Huynh MT, Filart R. Frequency-Specific Microcurrent as Adjunctive Therapy for Three Wounded Warriors. Med Acupunct. 2019;31(3):189-192. PMC6604905.

• Moss DA, et al. Patients experience improvements in pain and quality of life when treated at a physician led integrative medicine clinic at a large air force military treatment facility. Advances in Integrative Medicine. 2024. doi:10.1016/j.aimed.2024.09.004.

• McMakin CR. Frequency Specific Microcurrent in Pain Management. Elsevier, 2010.

• McMakin CR. The Resonance Effect. North Atlantic Books, 2017.

Bioregulatory medicine is a total body (and mind) approach to health and healing that aims to help facilitate and restore natural human biological processes. It is a proven, safe, gentle, highly effective, drugless, and side-effect-free medical model designed to naturally support the body to regulate, adapt, regenerate, and self-heal. BRMI is a non-commercial 501(c)(3) foundation and will expand and flourish with your support. Our goal is to make bioregulatory medicine a household term.

This article is for informational purposes only and is not intended to be a substitute for the direct care of a qualified health practitioner who oversees and provides unique and individualized care. The information provided here is to broaden our different perspectives and should not be construed as medical advice, diagnosis, or treatment.